{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:03:48Z","timestamp":1787313828332,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Health","award":["R01DA046653"],"award-info":[{"award-number":["R01DA046653"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01464-4","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T04:54:38Z","timestamp":1777179278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Syringe service program utilization, behavioral, and experiential factors associated with greater naloxone protection in a longitudinal cohort of people who use illicit opioids in New York city"],"prefix":"10.1186","volume":"23","author":[{"given":"Alex S.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alverado","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemar R.","family":"Bather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody S.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luther","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/20250305008","author":"FB Ahmad","year":"2024","unstructured":"Ahmad FB, et al. Provisional drug overdose death counts. Nat Center Health Statist. 2024. https:\/\/doi.org\/10.15620\/cdc\/20250305008.","journal-title":"Nat Center Health Statist"},{"issue":"3","key":"1464_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/add.15233","volume":"116","author":"D Furr-Holden","year":"2021","unstructured":"Furr-Holden D, et al. African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018. Addiction. 2021;116(3):677\u201383.","journal-title":"Addiction"},{"key":"1464_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106625","volume":"112","author":"M Cano","year":"2021","unstructured":"Cano M. Racial\/ethnic differences in US drug overdose mortality, 2017-2018. Addict Behav. 2021;112:106625. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106625.","journal-title":"Addict Behav"},{"key":"1464_CR4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7331a1","author":"FB Ahmad","year":"2024","unstructured":"Ahmad FB. Mortality in the United States\u2014provisional data, 2023. MMWR Morb Mortal Wkly Rep. 2024. https:\/\/doi.org\/10.15585\/mmwr.mm7331a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1464_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109859","volume":"246","author":"R Romero","year":"2023","unstructured":"Romero R, et al. US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021. Drug Alcohol Depend. 2023;246:109859.","journal-title":"Drug Alcohol Depend"},{"key":"1464_CR6","doi-asserted-by":"publisher","first-page":"174550572413070","DOI":"10.1177\/17455057241307088","volume":"20","author":"AA Jones","year":"2024","unstructured":"Jones AA, et al. Drug overdose deaths among women 1999\u20132021 in the United States: differences by race, ethnicity, and age. Womens Health (Lond). 2024;20:17455057241307088.","journal-title":"Womens Health (Lond)"},{"issue":"1","key":"1464_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12954-025-01266-0","volume":"22","author":"B Hervera","year":"2025","unstructured":"Hervera B, et al. Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida. Harm Reduct J. 2025;22(1):117.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1464_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01116-5","volume":"21","author":"JD Scheidell","year":"2024","unstructured":"Scheidell JD, et al. Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities. Harm Reduct J. 2024;21(1):198.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1464_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00736-7","volume":"20","author":"MR Khan","year":"2023","unstructured":"Khan MR, et al. Racial\/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York city. Harm Reduct J. 2023;20(1):24.","journal-title":"Harm Reduct J"},{"issue":"33","key":"1464_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6933a2","volume":"69","author":"BH Lambdin","year":"2020","unstructured":"Lambdin BH, et al. Overdose education and naloxone distribution within syringe service programs\u2014United States, 2019. Morb Mortal Wkly Rep. 2020;69(33):1117.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"1464_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/add.15163","volume":"116","author":"R Smart","year":"2021","unstructured":"Smart R, Pardo B, Davis CS. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction. 2021;116(1):6\u201317.","journal-title":"Addiction"},{"key":"1464_CR12","doi-asserted-by":"crossref","unstructured":"Saloner B et al. Harm reduction: the Neglected Pillar of US drug policy. In: Annual review of public health, 2025. 46(Vol. 46, 2025): p. 369\u2013387.","DOI":"10.1146\/annurev-publhealth-071723-112620"},{"key":"1464_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2021.03.001","volume":"234","author":"AS Bennett","year":"2021","unstructured":"Bennett AS, Elliott L. Naloxone\u2019s role in the national opioid crisis\u2014past struggles, current efforts, and future opportunities. Transl Res. 2021;234:43\u201357.","journal-title":"Transl Res"},{"key":"1464_CR14","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/12054.001.0001","volume-title":"OD: naloxone and the politics of overdose","author":"ND Campbell","year":"2020","unstructured":"Campbell ND. OD: naloxone and the politics of overdose. Cambridge, Massachusetts: The MIT Press; 2020."},{"key":"1464_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","volume":"178","author":"R McDonald","year":"2017","unstructured":"McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014conception and maturation. Drug Alcohol Depend. 2017;178:176\u201387.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1464_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.socnet.2008.03.003","volume":"30","author":"N Braine","year":"2008","unstructured":"Braine N, et al. Neighborhood history as a factor shaping syringe distribution networks among drug users at a U. S. Syringe Exchange. Soc Netw. 2008;30(3):235\u201346.","journal-title":"Soc Netw"},{"issue":"7","key":"1464_CR17","doi-asserted-by":"publisher","first-page":"e2222149","DOI":"10.1001\/jamanetworkopen.2022.22149","volume":"5","author":"A Harocopos","year":"2022","unstructured":"Harocopos A, et al. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Netw Open. 2022;5(7):e2222149\u2013e2222149.","journal-title":"JAMA Netw Open"},{"key":"1464_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100317","volume":"14","author":"EO Chung","year":"2025","unstructured":"Chung EO, et al. Association of safer smoking supply distribution with participant encounters and naloxone distribution from syringe services programs: findings from the national survey of syringe services programs in the United States. Drug Alcohol Depend Rep. 2025;14:100317.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"1464_CR19","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1080\/07853890.2022.2121418","volume":"54","author":"ST Allen","year":"2022","unstructured":"Allen ST, et al. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Ann Med. 2022;54(1):2680\u20138.","journal-title":"Ann Med"},{"key":"1464_CR20","doi-asserted-by":"crossref","unstructured":"Capraro GA, Rebola CB. The NaloxBox program in Rhode Island: a model for community-access naloxone. In: 2018, American Journal of Public Health. p. 1649\u20131651.","DOI":"10.2105\/AJPH.2018.304735"},{"issue":"4","key":"1464_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11524-021-00534-1","volume":"98","author":"BT Hayes","year":"2021","unstructured":"Hayes BT, et al. Harm reduction, by mail: the next step in promoting the health of people who use drugs. J Urban Health. 2021;98(4):532\u20137.","journal-title":"J Urban Health"},{"issue":"S2","key":"1464_CR22","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.2105\/AJPH.2022.306767","volume":"112","author":"AM Lopez","year":"2022","unstructured":"Lopez AM, et al. Understanding racial inequities in the implementation of harm reduction initiatives. Am J Public Health. 2022;112(S2):S173\u201381.","journal-title":"Am J Public Health"},{"issue":"12","key":"1464_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/22411","volume":"4","author":"AS Bennett","year":"2020","unstructured":"Bennett AS, et al. Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study. JMIR Form Res. 2020;4(12):e22411.","journal-title":"JMIR Form Res"},{"issue":"11","key":"1464_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224686","volume":"14","author":"L Dayton","year":"2019","unstructured":"Dayton L, et al. More than just availability: who has access and who administers take-home naloxone in Baltimore, MD. PLoS ONE. 2019;14(11):e0224686.","journal-title":"PLoS ONE"},{"key":"1464_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","volume":"51","author":"SC Heavey","year":"2018","unstructured":"Heavey SC, et al. \u2018I have it just in case\u2019\u2014Naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018;51:27\u201335.","journal-title":"Int J Drug Policy"},{"key":"1464_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209616","author":"D Frank","year":"2025","unstructured":"Frank D, et al. \u201cI still can feel the sickness\u201d: withdrawal experiences of people on methadone maintenance treatment. J Subst Use Addict Treat. 2025. https:\/\/doi.org\/10.1016\/j.josat.2024.209616.","journal-title":"J Subst Use Addict Treat"},{"issue":"10077","key":"1464_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey ZD, et al. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1464_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/epirev\/mxad004","volume":"45","author":"MM Wizentier","year":"2023","unstructured":"Wizentier MM, Stephenson BJK, Goodman MS. The measurement of racism in health inequities research. Epidemiol Rev. 2023;45(1):32\u201343.","journal-title":"Epidemiol Rev"},{"key":"1464_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-publhealth-040218-043750","volume":"40","author":"DR Williams","year":"2019","unstructured":"Williams DR, Lawrence JA, Davis BA. Racism and health: evidence and needed research. Annu Rev Public Health. 2019;40:105\u201325.","journal-title":"Annu Rev Public Health"},{"key":"1464_CR30","doi-asserted-by":"crossref","unstructured":"Scott M, Wahl O. Substance abuse stigma and discrimination among African American male substance users. In: Stigma research and action, 2011. 1.","DOI":"10.5463\/sra.v1i1.3"},{"key":"1464_CR31","unstructured":"Lewis C. A look inside NYC\u2019s supervised drug-injection sites. In: The First In The Nation. 2021."},{"key":"1464_CR32","unstructured":"NYCDOHMH, Unintentional drug poisoning (Overdose) deaths in New York city in 2021. In: Epi data brief, 2023. 133."},{"issue":"1","key":"1464_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00604-w","volume":"19","author":"AS Bennett","year":"2022","unstructured":"Bennett AS, et al. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City. Harm Reduct J. 2022;19(1):1\u201315.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1464_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/add.16103","volume":"118","author":"JG Rosen","year":"2023","unstructured":"Rosen JG, et al. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction. 2023;118(5):847\u201354.","journal-title":"Addiction"},{"key":"1464_CR35","doi-asserted-by":"publisher","first-page":"104914","DOI":"10.1016\/j.drugpo.2025.104914","volume":"143","author":"C Latkin","year":"2025","unstructured":"Latkin C, et al. Having naloxone when you need it: factors associated with owning and carrying naloxone among people who use opioids. Int J Drug Policy. 2025;143:104914\u2013104914.","journal-title":"Int J Drug Policy"},{"key":"1464_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104572","volume":"133","author":"J Akhurst","year":"2024","unstructured":"Akhurst J, et al. Naloxone cascade of care among people who regularly inject drugs in Australia, 2020\u20132022. Int J Drug Policy. 2024;133:104572.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"1464_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307151","volume":"19","author":"AM Roth","year":"2024","unstructured":"Roth AM, et al. Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic. PLoS ONE. 2024;19(7):e0307151.","journal-title":"PLoS ONE"},{"key":"1464_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103253","volume":"95","author":"R McDonald","year":"2021","unstructured":"McDonald R, et al. Rethinking \u2018carriage\u2019of take-home naloxone. Int J Drug Policy. 2021;95:103253.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1464_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12954-022-00604-w","volume":"19","author":"AS Bennett","year":"2022","unstructured":"Bennett AS, et al. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City. Harm Reduct J. 2022;19(1):20.","journal-title":"Harm Reduct J"},{"key":"1464_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103554","volume":"101","author":"AS Bennett","year":"2022","unstructured":"Bennett AS, Townsend T, Elliott L. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months. Int J Drug Policy. 2022;101:103554.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1464_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-Driven Sampling: A new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399.","journal-title":"Soc Probl"},{"issue":"1","key":"1464_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1467-9531.2007.00188.x","volume":"37","author":"DD Heckathorn","year":"2007","unstructured":"Heckathorn DD. Extensions of Respondent-Driven Sampling: Analyzing continuous variables and controlling for differential recruitment. Sociol Methodol. 2007;37(1):151\u2013207.","journal-title":"Sociol Methodol"},{"issue":"1","key":"1464_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/aje\/kwx208","volume":"187","author":"FW Crawford","year":"2018","unstructured":"Crawford FW, et al. Identification of homophily and preferential recruitment in respondent-driven sampling. Am J Epidemiol. 2018;187(1):153\u201360.","journal-title":"Am J Epidemiol"},{"key":"1464_CR44","first-page":"38","volume":"5","author":"LG Johnston","year":"2010","unstructured":"Johnston LG, Sabin KM. Sampling hard-to-reach populations with Respondent Driven Sampling. Methodol Innov Online. 2010;5:38\u201348.","journal-title":"Methodol Innov Online"},{"key":"1464_CR45","unstructured":"Mackey KM, Beech EH, Williams BE, Andreson JK, Young S, Parr NJ. Effectiveness of syringe services programs: a systematic review. In: 2023, Department of Veteran Affairs Washington, DC."},{"issue":"3","key":"1464_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08897077.2017.1282914","volume":"38","author":"ER Pouget","year":"2017","unstructured":"Pouget ER, et al. Development of an opioid-related overdose risk behavior scale (ORBS). Subst Abuse. 2017;38(3):239\u201344.","journal-title":"Subst Abuse"},{"key":"1464_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108721","volume":"223","author":"L Elliott","year":"2021","unstructured":"Elliott L, et al. Validation of the opioid overdose risk behavior scale, version 2 (ORBS-2). Drug Alcohol Depend. 2021;223:108721.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1464_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/occmed\/kqn181","volume":"59","author":"CA Jackson","year":"2009","unstructured":"Jackson CA. The life events inventory (LEI). Occup Med. 2009;59(3):208\u2013208.","journal-title":"Occup Med"},{"key":"1464_CR49","first-page":"143","volume-title":"The brief pain inventory","author":"CS Cleeland","year":"1991","unstructured":"Cleeland CS, Ryan K. The brief pain inventory. Pain Research Group; 1991. p. 143\u20137."},{"key":"1464_CR50","unstructured":"Cleeland CS, The brief pain inventory user guide. 2009, Houston: University of Texas, retrieved online at https:\/\/www.mdanderson.org\/documents\/Departments-and-Divisions\/Symptom-Research\/BPI_UserGuide.pdf."},{"key":"1464_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107734","volume":"206","author":"CM Cleland","year":"2020","unstructured":"Cleland CM, et al. Between-and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference. Drug Alcohol Depend. 2020;206:107734.","journal-title":"Drug Alcohol Depend"},{"key":"1464_CR52","unstructured":"Lash TL et al. Modern epidemiology. In: 2020: Lippincott Williams & Wilkins."},{"key":"1464_CR53","doi-asserted-by":"publisher","DOI":"10.1201\/9781003456285","volume-title":"Statistical inference","author":"G Casella","year":"2024","unstructured":"Casella G, Berger R. Statistical inference. CRC press; 2024."},{"key":"1464_CR54","doi-asserted-by":"crossref","unstructured":"Zinsli KA et al. Trends and correlates of naloxone possession and use among people who inject drugs in Seattle, Washington. In: International Journal of Drug Policy, 2023: p. 104272.","DOI":"10.1016\/j.drugpo.2023.104272"},{"key":"1464_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102778","volume":"90","author":"K Kim","year":"2021","unstructured":"Kim K, et al. Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco. Int J Drug Policy. 2021;90:102778.","journal-title":"Int J Drug Policy"},{"key":"1464_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100054","volume":"3","author":"JD Scheidell","year":"2022","unstructured":"Scheidell JD, et al. Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City. Drug Alcohol Depend Rep. 2022;3:100054.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"10","key":"1464_CR57","doi-asserted-by":"publisher","first-page":"e2021066","DOI":"10.1001\/jamanetworkopen.2020.21066","volume":"3","author":"SM Goldenberg","year":"2020","unstructured":"Goldenberg SM. Addressing violence and overdose among women who use drugs\u2014need for structural interventions. JAMA Netw Open. 2020;3(10):e2021066\u2013e2021066.","journal-title":"JAMA Netw Open"},{"key":"1464_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112384","volume":"234","author":"AB Collins","year":"2019","unstructured":"Collins AB, et al. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234:112384.","journal-title":"Soc Sci Med"},{"issue":"12","key":"1464_CR59","first-page":"2261","volume":"113","author":"J Boyd","year":"2018","unstructured":"Boyd J, et al. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver. Canada Add. 2018;113(12):2261\u201370.","journal-title":"Canada Add"},{"key":"1464_CR60","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/QAI.0000000000000624","volume":"69","author":"SA Strathdee","year":"2015","unstructured":"Strathdee SA, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. JAIDS J Acquired Immune Def Synd. 2015;69:S110\u20137.","journal-title":"JAIDS J Acquired Immune Def Synd"},{"issue":"1","key":"1464_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12954-020-00436-6","volume":"17","author":"K Papamihali","year":"2020","unstructured":"Papamihali K, et al. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada. Harm Reduct J. 2020;17(1):90.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1464_CR62","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11524-024-00951-y","volume":"102","author":"CN Behrends","year":"2025","unstructured":"Behrends CN, et al. Expanded Naloxone distribution by opioid overdose prevention programs to high-need populations and neighborhoods in New York City. J Urban Health. 2025;102(2):459\u201364.","journal-title":"J Urban Health"},{"key":"1464_CR63","doi-asserted-by":"publisher","DOI":"10.2196\/56755","volume":"8","author":"ID Aronson","year":"2024","unstructured":"Aronson ID, et al. Barriers to, and facilitators of, checking drugs for adulterants in the era of fentanyl and Xylazine: qualitative study. JMIR Format Res. 2024;8:e56755.","journal-title":"JMIR Format Res"},{"issue":"4","key":"1464_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/YCO.0000000000000607","volume":"33","author":"JJ Palamar","year":"2020","unstructured":"Palamar JJ, Salomone A, Barratt MJ. Drug checking to detect Fentanyl and new psychoactive substances. Curr Opin Psychiatry. 2020;33(4):301\u20135.","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"1464_CR65","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344.","journal-title":"Addiction"},{"key":"1464_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103196","volume":"94","author":"JN Park","year":"2021","unstructured":"Park JN, et al. Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. Int J Drug Policy. 2021;94:103196.","journal-title":"Int J Drug Policy"},{"key":"1464_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker NP, et al. Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1464_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12954-023-00891-x","volume":"20","author":"S Nolen","year":"2023","unstructured":"Nolen S, et al. Racial\/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City. Harm Reduct J. 2023;20(1):152.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1464_CR69","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12954-024-01070-2","volume":"21","author":"G Luna","year":"2024","unstructured":"Luna G, Dermid G, Unger JB. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review. Harm Reduct J. 2024;21(1):150.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1464_CR70","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/10714839.2020.1809078","volume":"52","author":"C Gelp\u00ed-Acosta","year":"2020","unstructured":"Gelp\u00ed-Acosta C, Oyola-Santiago T. Dispatches from rebellious colonial subjects: harm reduction activism to humanize and support people who inject drugs in Puerto Rico and the New York City Puerto Rican diaspora charts a long and unfinished history. It is a story of half victories and, above all, interminable struggles. NACLA Rep Am. 2020;52(3):252\u20139.","journal-title":"NACLA Rep Am"},{"key":"1464_CR71","unstructured":"NYC Health & Hospitals. NYC Health and Hospitals\/Correctional Health Services Announces More Than 13,000 Naloxone Kits Have Been Distributed at NYC Jail Visitor Centers. 2018: NYC."},{"key":"1464_CR72","volume-title":"Creating the American junkie: addiction research in the classic era of narcotic control","author":"CJ Acker","year":"2002","unstructured":"Acker CJ. Creating the American junkie: addiction research in the classic era of narcotic control. Baltimore: Johns Hopkins University Press; 2002."},{"key":"1464_CR73","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctv33f0zpn","volume-title":"Whiteout: how racial capitalism changed the color of opioids in America","author":"H Hansen","year":"2023","unstructured":"Hansen H, Netherland J, Herzberg D. Whiteout: how racial capitalism changed the color of opioids in America. University of California Press; 2023."},{"issue":"8","key":"1464_CR74","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/add.14608","volume":"114","author":"L Elliott","year":"2019","unstructured":"Elliott L, Bennett AS, Wolfson-Stofko B. Life after opioid-involved overdose: survivor narratives and their implications for ER\/ED interventions. Addiction. 2019;114(8):1379\u201386.","journal-title":"Addiction"},{"key":"1464_CR75","doi-asserted-by":"publisher","DOI":"10.1177\/00220426231168081","author":"L Elliott","year":"2023","unstructured":"Elliott L, et al. Distal factors associated with proximal overdose risk behaviors and recent non-fatal overdose among a sample of people who use illicit opioids in New York City. J Drug Issues. 2023. https:\/\/doi.org\/10.1177\/00220426231168081.","journal-title":"J Drug Issues"},{"key":"1464_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-025-01050-2","author":"ID Aronson","year":"2026","unstructured":"Aronson ID, Cramer A, Quiles R, Marcus O, Gibson B, Vargas-Estrella B, et al. Developing Spanish language intervention content to address health disparities among people who use drugs, and other hard-to-reach populations. J Urban Health. 2026. https:\/\/doi.org\/10.1007\/s11524-025-01050-2.","journal-title":"J Urban Health"},{"key":"1464_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100757","author":"BR Ray","year":"2024","unstructured":"Ray BR, et al. Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey. Lancet Reg Health Am. 2024. https:\/\/doi.org\/10.1016\/j.lana.2024.100757.","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"1464_CR78","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/00914509251346135","volume":"52","author":"D Frank","year":"2025","unstructured":"Frank D, et al. An examination of how people who use drugs conceptualize the benefits and drawbacks of using overdose prevention centers. Contemp Drug Probl. 2025;52(4):584\u201397.","journal-title":"Contemp Drug Probl"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01464-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:03:14Z","timestamp":1781092994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01464-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01464-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7926376\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"99"}}